Health Care & Life Sciences » Pharmaceuticals | Spectrum Pharmaceuticals Inc.

Spectrum Pharmaceuticals Inc.

Spectrum Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.17
Market Cap
$891.75 M
Shares Outstanding
104.06 M
Public Float
98.23 M

Profile

Address
11500 South Eastern Avenue
Henderson Nevada 89052
United States
Employees -
Website http://www.sppirx.com
Updated 07/08/2019
Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development, and commercialization of pipeline of late-stage clinical and commercial products. It operates through the following brands: FOLOTYN, ZEVALIN, MARQIBO, BELEODAQ, and EVOMELA. The company was founded in December 1987 and is headquartered in Henderson, NV.

Financials

View All

Stuart Mitchell Krassner
Chairman
Joseph W. Turgeon
President, Chief Executive Officer & Director